Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CNTB
CONNECT BIOPHARMA HOLDINGS LIMITED
NASDAQ
$2.23
▼ DOWN 2.19% (-0.05)

KEY STATISTICS

Market Cap$140.41 M
52w High$3.82
52w Low$1.23
Dividend Yield—
Frequency—
P/E-3.66
Volume339.08K
Shares Out.62.96M

COMPANY

LEADERSHIP

Barry D. Quart
CHIEF EXECUTIVE
Barry D. Quart

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 19, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
64

PRICE TARGET

Target High$8.00
Target Low$4.00
Target Median$7.00
Target Consensus$6.60

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$114.70K
NOV
11
WED

PRICE

$2.23 ▼ DOWN 2.19% (−$0.05)
$2.20$2.24$2.28$2.329:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.23

About Connect Biopharma Holdings Limited

https://www.connectbiopharma.com ↗

Connect Biopharma is a clinical-stage biotech developing immune modulators like CBP-201 for autoimmune and inflammatory diseases, with several candidates in Phase II and preclinical stages.

INDUSTRY

Biotechnology

A PRODUCT CONNECT BIOPHARMA HOLDINGS LIMITED IS KNOWN FOR

Rademikibart
Rademikibart

Rademikibart, Connect Biopharma's lead monoclonal antibody in clinical trials, targets T-cell driven inflammatory diseases like asthma and atopic dermatitis.

COMPETITORS

COMPETITOR
ABBV COMPARE
LLY COMPARE
PFE COMPARE
REGN COMPARE
SNY COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q4-2025Q2-2026
License$110M $0 ▼$99M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
26
LISTED HERE
6
RANKED BY POSITION SIZE
IWO
0.01% · 382.5K
VTWO
0.00% · 86.3K
RSSL
0.00% · 7.1K
URTY
0.00% · 611
FSEG
0.02% · 580
SC0K.DE
0.00% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
18.43%
HOLDERS
43
TOP 12 OF 43 · RANKED BY POSITION SIZE
Ikarian Capital, LLC
5.4M sh · $13.12M
Boothbay Fund Management, LLC
1.2M sh · $3.23M
683 Capital Management, LLC
900.0K sh · $2.36M
Perceptive Advisors LLC
792.7K sh · $2.08M
Adar1 Capital Management, LLC
742.4K sh · $1.95M
Richmond Brothers, Inc.
476.6K sh · $1.25M
Millennium Management LLC
474.6K sh · $1.24M
Bml Capital Management, LLC
408.9K sh · $1.07M
Knott David M Jr
387.8K sh · $1.02M
Stonepine Capital Management, LLC
310.0K sh · $812.2K
Susquehanna International Group, Llp
278.8K sh · $730.48K
Propel Bio Management, LLC
209.5K sh · $553.91K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Xanthopoulos Kleanthis Gabriel
Purchase · 3.7K shares
2026-06-30
★
DIRECTOR
LIU JEAN I
Purchase · 6.7K shares
2026-06-30
★
DIRECTOR
Huang James
Purchase · 150.0K shares
2026-05-29
★
DIRECTOR
LIU JEAN I
Purchase · 5.1K shares
2026-03-31

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OVERWEIGHT 1
3 GRADES IN THE LAST 12 MONTHS
Piper Sandler OVERWEIGHT HC Wainwright & Co. BUY BTIG BUY

SECTORS PEERS

PEERPRICE
STTK$7.04COMPARE
ARTV$11.09COMPARE
OVID$2.80COMPARE
IFRX$2.23COMPARE
STRO$20.45COMPARE
KLRS$4.03COMPARE
IMA$5.34COMPARE
MGX$1.19COMPARE